Shouvonik Sengupta

Shouvonik Sengupta is a Scientist 2 at Kyverna Therapeutics since February 2022, supporting IND/CTA enabling studies with in vivo autoimmune models for CAR T cell therapies. Prior experience includes serving as a Graduate Research Associate and Graduate Fellow at The Ohio State University College of Medicine from May 2017 to February 2022, and an internship at Denison Pharmaceuticals in June 2015 as a formulation and R&D intern. Shouvonik holds a Doctor of Philosophy in Biomedical Sciences, specializing in Immunology, from The Ohio State University, obtained in November 2021, and a Bachelor of Technology in Biotechnology from VIT University, completed in 2017. Educational background also includes attendance at National Public School, Koramangala, from 2004 to 2013.